Video

Treat-to-Target in Rheumatoid Arthritis

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Related Videos
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Image Credit: © Cavan - stock.adobe.com
Young female pharmacist working in her large pharmacy. Placing medications, taking inventory. Lifestyle - Image credit: lubero | stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Related Content
Stelara Biosimilar, Selarsdi, Psoriatic Arthritis, Plaque Psoriasis | Image Credit: Diego Cervo - stock.adobe.com
October 22nd 2024

FDA Approves Selarsdi as Biosimlar to Stelara in an Intravenous Formulation

Ashley Gallagher, Associate Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Frank Kessler at his Walmart pharmacy in Memphis, TN.
October 21st 2024

American Pharmacists Month: Frank Kessler Reflects on Decades of Work in Community Pharmacy

Luke Halpern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

FDA logo -- Image credit: Araki Illustrations | stock.adobe.com
October 15th 2024

FDA Approves Imuldosa, Stelara Biosimilar For Treatment of Chronic Inflammatory Conditions

Gillian McGovern, Assistant Editor
Marilyn Bulloch Doing Rounds in a Hospital With Physicians
October 14th 2024

Pharmacy Times Launches Behind The Script Campaign to Highlight Pharmacists